Analysis of pro-interleukin(IL)-1β mRNA after MCAO did not reveal a significant alteration between MT-II treated and vehicle-only treated mice after stroke (relative IL-1β expression 72h after 30min MCAO: vehicleMCAO 4 ± 1.5; MT-IIMCAO: 4.4 ± 1.3; p = n.s.)(Fig 6). This evidence concerns the gene IL1B and stroke disorder.